133 related articles for article (PubMed ID: 24364270)
1. [Pharmacokinetics of anesthesia related drugs in patients with chronic kidney disease].
Tsubokawa T
Masui; 2013 Nov; 62(11):1293-303. PubMed ID: 24364270
[TBL] [Abstract][Full Text] [Related]
2. Lessons learned in drug development from anesthesia.
Gambús PL; Stanski DR
Rev Esp Anestesiol Reanim; 2005; 52(6):311-4. PubMed ID: 16038169
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of drugs used in critically ill adults.
Power BM; Forbes AM; van Heerden PV; Ilett KF
Clin Pharmacokinet; 1998 Jan; 34(1):25-56. PubMed ID: 9474472
[TBL] [Abstract][Full Text] [Related]
4. Sedation Analgesia and Neuromuscular Blockade in Pediatric Critical Care: Overview and Current Landscape.
Zuppa AF; Curley MAQ
Pediatr Clin North Am; 2017 Oct; 64(5):1103-1116. PubMed ID: 28941538
[TBL] [Abstract][Full Text] [Related]
5. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
Yogaratnam D; Miller MA; Smith BS
Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
[TBL] [Abstract][Full Text] [Related]
6. [Constant-flow drug administration in anesthesia].
Richard JP; Bareille P; Pujol MP; Conil JM; Antonini A
Cah Anesthesiol; 1988 Sep; 36(5):365-6. PubMed ID: 2903791
[TBL] [Abstract][Full Text] [Related]
7. [Physical and pharmacokinetic properties of anesthetics and sedatives used in neuroanesthesia and resuscitation].
Egreteau JP; Guedes Y; L'Azou D
Agressologie; 1991; 32(8-9 Spec No):455-9. PubMed ID: 1844213
[TBL] [Abstract][Full Text] [Related]
8. [Anesthesia in obese patients--pharmacokinetic aspects].
Gjøderum O; Andersen BN
Ugeskr Laeger; 1995 Aug; 157(34):4691-4. PubMed ID: 7645119
[No Abstract] [Full Text] [Related]
9. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
[TBL] [Abstract][Full Text] [Related]
10. [Appropriate pharmacotherapy in patients with chronic kidney disease - new approach - ].
Hirata S
Yakugaku Zasshi; 2012; 132(4):461-70. PubMed ID: 22465923
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics from the viewpoint of the clinical anesthetist].
Röper A; Lauven PM
Anaesthesiol Reanim; 1997; 22(4):88-94. PubMed ID: 9376043
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery: physicochemical and therapeutic aspects.
Costantino HR; Illum L; Brandt G; Johnson PH; Quay SC
Int J Pharm; 2007 Jun; 337(1-2):1-24. PubMed ID: 17475423
[TBL] [Abstract][Full Text] [Related]
13. Dose adjustment of anaesthetics in the morbidly obese.
Ingrande J; Lemmens HJ
Br J Anaesth; 2010 Dec; 105 Suppl 1():i16-23. PubMed ID: 21148651
[TBL] [Abstract][Full Text] [Related]
14. (Almost) everything you learned about pharmacokinetics was (somewhat) wrong!
Fisher DM
Anesth Analg; 1996 Nov; 83(5):901-3. PubMed ID: 8895260
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
Walzer M; Bekersky I; Blum RA; Tolbert D
Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
[TBL] [Abstract][Full Text] [Related]
16. [Sedative practice in intensive care units results of a Maghrebian survey].
Kamel S; Tahar M; Nabil F; Mohamed R; Mhamed Sami M; Mohamed SB
Tunis Med; 2005 Nov; 83(11):657-63. PubMed ID: 16422361
[TBL] [Abstract][Full Text] [Related]
17. [Use of sedation, analgesia and neuromuscular blockade by intensive care units in Denmark 1996-1997].
Thunedborg LP; Christensen BV
Ugeskr Laeger; 2000 Apr; 162(17):2442-6. PubMed ID: 10835972
[TBL] [Abstract][Full Text] [Related]
18. [Safe drug prescribing for patients with renal failure].
Tanaka A; Shimizu H; Matsuo S
Nihon Rinsho; 2007 Oct; 65 Suppl 8():58-66. PubMed ID: 18074518
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of dexrazoxane in subjects with impaired kidney function.
Brier ME; Gaylor SK; McGovren JP; Glue P; Fang A; Aronoff GR
J Clin Pharmacol; 2011 May; 51(5):731-8. PubMed ID: 20484616
[TBL] [Abstract][Full Text] [Related]
20. IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease.
Lepenies J; Wu Z; Stewart PM; Strasburger CJ; Quinkler M
Growth Horm IGF Res; 2010 Apr; 20(2):93-100. PubMed ID: 19932629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
